GANX GAIN THERAPEUTICS INC Management Changes 8-K Filing 2024 - CFO Appointment Gain Therapeutics, Inc. appointed Gene Mack as its Chief Financial Officer, effective April 8, 2024, and provided details of his employment agreement and compensatory arrangements.Get access to all SEC 8-K filings of the GAIN THERAPEUTICS INC